Global Genitourinary Drugs Market Growth 2025-2031

October 2025 | 79 pages | ID: GAD98ADC362EEN
LP Information

Abstracts

The global Genitourinary Drugs market size is predicted to grow from US$ 30670 million in 2025 to US$ 37530 million in 2031; it is expected to grow at a CAGR of 3.4% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

United States market for Genitourinary Drugs is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Genitourinary Drugs is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Genitourinary Drugs is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Genitourinary Drugs players cover Novartis AG, Genentech, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the ?Genitourinary Drugs Industry Forecast? looks at past sales and reviews total world Genitourinary Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Genitourinary Drugs sales for 2025 through 2031. With Genitourinary Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Genitourinary Drugs industry.

This Insight Report provides a comprehensive analysis of the global Genitourinary Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Genitourinary Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Genitourinary Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Genitourinary Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Genitourinary Drugs.

This report presents a comprehensive overview, market shares, and growth opportunities of Genitourinary Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Urologicals
• Hormonal Therapy
• Gynecological
• Anti-infectives

Segmentation by Application:

• Prostate Cancer
• Ovarian Cancer
• Bladder Cancer
• Cervical Cancer
• Renal Cancer
• Erectile Dysfunction
• Urinary Tract Infections
• Urinary Incontinence & Overactive Bladder
• Sexually Transmitted Diseases

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Novartis AG
• Genentech

Key Questions Addressed in this Report

What is the 10-year outlook for the global Genitourinary Drugs market?
What factors are driving Genitourinary Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Genitourinary Drugs market opportunities vary by end market size?
How does Genitourinary Drugs break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Genitourinary Drugs Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Genitourinary Drugs by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Genitourinary Drugs by Country/Region, 2020, 2024 & 2031
2.2 Genitourinary Drugs Segment by Type
  2.2.1 Urologicals
  2.2.2 Hormonal Therapy
  2.2.3 Gynecological
  2.2.4 Anti-infectives
2.3 Genitourinary Drugs Sales by Type
  2.3.1 Global Genitourinary Drugs Sales Market Share by Type (2020-2025)
  2.3.2 Global Genitourinary Drugs Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Genitourinary Drugs Sale Price by Type (2020-2025)
2.4 Genitourinary Drugs Segment by Application
  2.4.1 Prostate Cancer
  2.4.2 Ovarian Cancer
  2.4.3 Bladder Cancer
  2.4.4 Cervical Cancer
  2.4.5 Renal Cancer
  2.4.6 Erectile Dysfunction
  2.4.7 Urinary Tract Infections
  2.4.8 Urinary Incontinence & Overactive Bladder
  2.4.9 Sexually Transmitted Diseases
2.5 Genitourinary Drugs Sales by Application
  2.5.1 Global Genitourinary Drugs Sale Market Share by Application (2020-2025)
  2.5.2 Global Genitourinary Drugs Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Genitourinary Drugs Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Genitourinary Drugs Breakdown Data by Company
  3.1.1 Global Genitourinary Drugs Annual Sales by Company (2020-2025)
  3.1.2 Global Genitourinary Drugs Sales Market Share by Company (2020-2025)
3.2 Global Genitourinary Drugs Annual Revenue by Company (2020-2025)
  3.2.1 Global Genitourinary Drugs Revenue by Company (2020-2025)
  3.2.2 Global Genitourinary Drugs Revenue Market Share by Company (2020-2025)
3.3 Global Genitourinary Drugs Sale Price by Company
3.4 Key Manufacturers Genitourinary Drugs Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Genitourinary Drugs Product Location Distribution
  3.4.2 Players Genitourinary Drugs Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR GENITOURINARY DRUGS BY GEOGRAPHIC REGION

4.1 World Historic Genitourinary Drugs Market Size by Geographic Region (2020-2025)
  4.1.1 Global Genitourinary Drugs Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Genitourinary Drugs Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Genitourinary Drugs Market Size by Country/Region (2020-2025)
  4.2.1 Global Genitourinary Drugs Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Genitourinary Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Genitourinary Drugs Sales Growth
4.4 APAC Genitourinary Drugs Sales Growth
4.5 Europe Genitourinary Drugs Sales Growth
4.6 Middle East & Africa Genitourinary Drugs Sales Growth

5 AMERICAS

5.1 Americas Genitourinary Drugs Sales by Country
  5.1.1 Americas Genitourinary Drugs Sales by Country (2020-2025)
  5.1.2 Americas Genitourinary Drugs Revenue by Country (2020-2025)
5.2 Americas Genitourinary Drugs Sales by Type (2020-2025)
5.3 Americas Genitourinary Drugs Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Genitourinary Drugs Sales by Region
  6.1.1 APAC Genitourinary Drugs Sales by Region (2020-2025)
  6.1.2 APAC Genitourinary Drugs Revenue by Region (2020-2025)
6.2 APAC Genitourinary Drugs Sales by Type (2020-2025)
6.3 APAC Genitourinary Drugs Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Genitourinary Drugs by Country
  7.1.1 Europe Genitourinary Drugs Sales by Country (2020-2025)
  7.1.2 Europe Genitourinary Drugs Revenue by Country (2020-2025)
7.2 Europe Genitourinary Drugs Sales by Type (2020-2025)
7.3 Europe Genitourinary Drugs Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Genitourinary Drugs by Country
  8.1.1 Middle East & Africa Genitourinary Drugs Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Genitourinary Drugs Revenue by Country (2020-2025)
8.2 Middle East & Africa Genitourinary Drugs Sales by Type (2020-2025)
8.3 Middle East & Africa Genitourinary Drugs Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Genitourinary Drugs
10.3 Manufacturing Process Analysis of Genitourinary Drugs
10.4 Industry Chain Structure of Genitourinary Drugs

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Genitourinary Drugs Distributors
11.3 Genitourinary Drugs Customer

12 WORLD FORECAST REVIEW FOR GENITOURINARY DRUGS BY GEOGRAPHIC REGION

12.1 Global Genitourinary Drugs Market Size Forecast by Region
  12.1.1 Global Genitourinary Drugs Forecast by Region (2026-2031)
  12.1.2 Global Genitourinary Drugs Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Genitourinary Drugs Forecast by Type (2026-2031)
12.7 Global Genitourinary Drugs Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Novartis AG
  13.1.1 Novartis AG Company Information
  13.1.2 Novartis AG Genitourinary Drugs Product Portfolios and Specifications
  13.1.3 Novartis AG Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Novartis AG Main Business Overview
  13.1.5 Novartis AG Latest Developments
13.2 Genentech
  13.2.1 Genentech Company Information
  13.2.2 Genentech Genitourinary Drugs Product Portfolios and Specifications
  13.2.3 Genentech Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Genentech Main Business Overview
  13.2.5 Genentech Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Genitourinary Drugs Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Genitourinary Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Urologicals
Table 4. Major Players of Hormonal Therapy
Table 5. Major Players of Gynecological
Table 6. Major Players of Anti-infectives
Table 7. Global Genitourinary Drugs Sales by Type (2020-2025) & (K Units)
Table 8. Global Genitourinary Drugs Sales Market Share by Type (2020-2025)
Table 9. Global Genitourinary Drugs Revenue by Type (2020-2025) & ($ million)
Table 10. Global Genitourinary Drugs Revenue Market Share by Type (2020-2025)
Table 11. Global Genitourinary Drugs Sale Price by Type (2020-2025) & (USD/Unit)
Table 12. Global Genitourinary Drugs Sale by Application (2020-2025) & (K Units)
Table 13. Global Genitourinary Drugs Sale Market Share by Application (2020-2025)
Table 14. Global Genitourinary Drugs Revenue by Application (2020-2025) & ($ million)
Table 15. Global Genitourinary Drugs Revenue Market Share by Application (2020-2025)
Table 16. Global Genitourinary Drugs Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Genitourinary Drugs Sales by Company (2020-2025) & (K Units)
Table 18. Global Genitourinary Drugs Sales Market Share by Company (2020-2025)
Table 19. Global Genitourinary Drugs Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Genitourinary Drugs Revenue Market Share by Company (2020-2025)
Table 21. Global Genitourinary Drugs Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Genitourinary Drugs Producing Area Distribution and Sales Area
Table 23. Players Genitourinary Drugs Products Offered
Table 24. Genitourinary Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Genitourinary Drugs Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Genitourinary Drugs Sales Market Share Geographic Region (2020-2025)
Table 29. Global Genitourinary Drugs Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Genitourinary Drugs Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Genitourinary Drugs Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Genitourinary Drugs Sales Market Share by Country/Region (2020-2025)
Table 33. Global Genitourinary Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Genitourinary Drugs Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Genitourinary Drugs Sales by Country (2020-2025) & (K Units)
Table 36. Americas Genitourinary Drugs Sales Market Share by Country (2020-2025)
Table 37. Americas Genitourinary Drugs Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Genitourinary Drugs Sales by Type (2020-2025) & (K Units)
Table 39. Americas Genitourinary Drugs Sales by Application (2020-2025) & (K Units)
Table 40. APAC Genitourinary Drugs Sales by Region (2020-2025) & (K Units)
Table 41. APAC Genitourinary Drugs Sales Market Share by Region (2020-2025)
Table 42. APAC Genitourinary Drugs Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Genitourinary Drugs Sales by Type (2020-2025) & (K Units)
Table 44. APAC Genitourinary Drugs Sales by Application (2020-2025) & (K Units)
Table 45. Europe Genitourinary Drugs Sales by Country (2020-2025) & (K Units)
Table 46. Europe Genitourinary Drugs Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Genitourinary Drugs Sales by Type (2020-2025) & (K Units)
Table 48. Europe Genitourinary Drugs Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Genitourinary Drugs Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Genitourinary Drugs Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Genitourinary Drugs Sales by Type (2020-2025) & (K Units)
Table 52. Middle East & Africa Genitourinary Drugs Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Genitourinary Drugs
Table 54. Key Market Challenges & Risks of Genitourinary Drugs
Table 55. Key Industry Trends of Genitourinary Drugs
Table 56. Genitourinary Drugs Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Genitourinary Drugs Distributors List
Table 59. Genitourinary Drugs Customer List
Table 60. Global Genitourinary Drugs Sales Forecast by Region (2026-2031) & (K Units)
Table 61. Global Genitourinary Drugs Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Genitourinary Drugs Sales Forecast by Country (2026-2031) & (K Units)
Table 63. Americas Genitourinary Drugs Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Genitourinary Drugs Sales Forecast by Region (2026-2031) & (K Units)
Table 65. APAC Genitourinary Drugs Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Genitourinary Drugs Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Europe Genitourinary Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Genitourinary Drugs Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Genitourinary Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Genitourinary Drugs Sales Forecast by Type (2026-2031) & (K Units)
Table 71. Global Genitourinary Drugs Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Genitourinary Drugs Sales Forecast by Application (2026-2031) & (K Units)
Table 73. Global Genitourinary Drugs Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Novartis AG Basic Information, Genitourinary Drugs Manufacturing Base, Sales Area and Its Competitors
Table 75. Novartis AG Genitourinary Drugs Product Portfolios and Specifications
Table 76. Novartis AG Genitourinary Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Novartis AG Main Business
Table 78. Novartis AG Latest Developments
Table 79. Genentech Basic Information, Genitourinary Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. Genentech Genitourinary Drugs Product Portfolios and Specifications
Table 81. Genentech Genitourinary Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Genentech Main Business
Table 83. Genentech Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Genitourinary Drugs
Figure 2. Genitourinary Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Genitourinary Drugs Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Genitourinary Drugs Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Genitourinary Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Genitourinary Drugs Sales Market Share by Country/Region (2024)
Figure 10. Genitourinary Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Urologicals
Figure 12. Product Picture of Hormonal Therapy
Figure 13. Product Picture of Gynecological
Figure 14. Product Picture of Anti-infectives
Figure 15. Global Genitourinary Drugs Sales Market Share by Type in 2025
Figure 16. Global Genitourinary Drugs Revenue Market Share by Type (2020-2025)
Figure 17. Genitourinary Drugs Consumed in Prostate Cancer
Figure 18. Global Genitourinary Drugs Market: Prostate Cancer (2020-2025) & (K Units)
Figure 19. Genitourinary Drugs Consumed in Ovarian Cancer
Figure 20. Global Genitourinary Drugs Market: Ovarian Cancer (2020-2025) & (K Units)
Figure 21. Genitourinary Drugs Consumed in Bladder Cancer
Figure 22. Global Genitourinary Drugs Market: Bladder Cancer (2020-2025) & (K Units)
Figure 23. Genitourinary Drugs Consumed in Cervical Cancer
Figure 24. Global Genitourinary Drugs Market: Cervical Cancer (2020-2025) & (K Units)
Figure 25. Genitourinary Drugs Consumed in Renal Cancer
Figure 26. Global Genitourinary Drugs Market: Renal Cancer (2020-2025) & (K Units)
Figure 27. Genitourinary Drugs Consumed in Erectile Dysfunction
Figure 28. Global Genitourinary Drugs Market: Erectile Dysfunction (2020-2025) & (K Units)
Figure 29. Genitourinary Drugs Consumed in Urinary Tract Infections
Figure 30. Global Genitourinary Drugs Market: Urinary Tract Infections (2020-2025) & (K Units)
Figure 31. Genitourinary Drugs Consumed in Urinary Incontinence & Overactive Bladder
Figure 32. Global Genitourinary Drugs Market: Urinary Incontinence & Overactive Bladder (2020-2025) & (K Units)
Figure 33. Genitourinary Drugs Consumed in Sexually Transmitted Diseases
Figure 34. Global Genitourinary Drugs Market: Sexually Transmitted Diseases (2020-2025) & (K Units)
Figure 35. Global Genitourinary Drugs Sale Market Share by Application (2024)
Figure 36. Global Genitourinary Drugs Revenue Market Share by Application in 2025
Figure 37. Genitourinary Drugs Sales by Company in 2025 (K Units)
Figure 38. Global Genitourinary Drugs Sales Market Share by Company in 2025
Figure 39. Genitourinary Drugs Revenue by Company in 2025 ($ millions)
Figure 40. Global Genitourinary Drugs Revenue Market Share by Company in 2025
Figure 41. Global Genitourinary Drugs Sales Market Share by Geographic Region (2020-2025)
Figure 42. Global Genitourinary Drugs Revenue Market Share by Geographic Region in 2025
Figure 43. Americas Genitourinary Drugs Sales 2020-2025 (K Units)
Figure 44. Americas Genitourinary Drugs Revenue 2020-2025 ($ millions)
Figure 45. APAC Genitourinary Drugs Sales 2020-2025 (K Units)
Figure 46. APAC Genitourinary Drugs Revenue 2020-2025 ($ millions)
Figure 47. Europe Genitourinary Drugs Sales 2020-2025 (K Units)
Figure 48. Europe Genitourinary Drugs Revenue 2020-2025 ($ millions)
Figure 49. Middle East & Africa Genitourinary Drugs Sales 2020-2025 (K Units)
Figure 50. Middle East & Africa Genitourinary Drugs Revenue 2020-2025 ($ millions)
Figure 51. Americas Genitourinary Drugs Sales Market Share by Country in 2025
Figure 52. Americas Genitourinary Drugs Revenue Market Share by Country (2020-2025)
Figure 53. Americas Genitourinary Drugs Sales Market Share by Type (2020-2025)
Figure 54. Americas Genitourinary Drugs Sales Market Share by Application (2020-2025)
Figure 55. United States Genitourinary Drugs Revenue Growth 2020-2025 ($ millions)
Figure 56. Canada Genitourinary Drugs Revenue Growth 2020-2025 ($ millions)
Figure 57. Mexico Genitourinary Drugs Revenue Growth 2020-2025 ($ millions)
Figure 58. Brazil Genitourinary Drugs Revenue Growth 2020-2025 ($ millions)
Figure 59. APAC Genitourinary Drugs Sales Market Share by Region in 2025
Figure 60. APAC Genitourinary Drugs Revenue Market Share by Region (2020-2025)
Figure 61. APAC Genitourinary Drugs Sales Market Share by Type (2020-2025)
Figure 62. APAC Genitourinary Drugs Sales Market Share by Application (2020-2025)
Figure 63. China Genitourinary Drugs Revenue Growth 2020-2025 ($ millions)
Figure 64. Japan Genitourinary Drugs Revenue Growth 2020-2025 ($ millions)
Figure 65. South Korea Genitourinary Drugs Revenue Growth 2020-2025 ($ millions)
Figure 66. Southeast Asia Genitourinary Drugs Revenue Growth 2020-2025 ($ millions)
Figure 67. India Genitourinary Drugs Revenue Growth 2020-2025 ($ millions)
Figure 68. Australia Genitourinary Drugs Revenue Growth 2020-2025 ($ millions)
Figure 69. China Taiwan Genitourinary Drugs Revenue Growth 2020-2025 ($ millions)
Figure 70. Europe Genitourinary Drugs Sales Market Share by Country in 2025
Figure 71. Europe Genitourinary Drugs Revenue Market Share by Country (2020-2025)
Figure 72. Europe Genitourinary Drugs Sales Market Share by Type (2020-2025)
Figure 73. Europe Genitourinary Drugs Sales Market Share by Application (2020-2025)
Figure 74. Germany Genitourinary Drugs Revenue Growth 2020-2025 ($ millions)
Figure 75. France Genitourinary Drugs Revenue Growth 2020-2025 ($ millions)
Figure 76. UK Genitourinary Drugs Revenue Growth 2020-2025 ($ millions)
Figure 77. Italy Genitourinary Drugs Revenue Growth 2020-2025 ($ millions)
Figure 78. Russia Genitourinary Drugs Revenue Growth 2020-2025 ($ millions)
Figure 79. Middle East & Africa Genitourinary Drugs Sales Market Share by Country (2020-2025)
Figure 80. Middle East & Africa Genitourinary Drugs Sales Market Share by Type (2020-2025)
Figure 81. Middle East & Africa Genitourinary Drugs Sales Market Share by Application (2020-2025)
Figure 82. Egypt Genitourinary Drugs Revenue Growth 2020-2025 ($ millions)
Figure 83. South Africa Genitourinary Drugs Revenue Growth 2020-2025 ($ millions)
Figure 84. Israel Genitourinary Drugs Revenue Growth 2020-2025 ($ millions)
Figure 85. Turkey Genitourinary Drugs Revenue Growth 2020-2025 ($ millions)
Figure 86. GCC Countries Genitourinary Drugs Revenue Growth 2020-2025 ($ millions)
Figure 87. Manufacturing Cost Structure Analysis of Genitourinary Drugs in 2025
Figure 88. Manufacturing Process Analysis of Genitourinary Drugs
Figure 89. Industry Chain Structure of Genitourinary Drugs
Figure 90. Channels of Distribution
Figure 91. Global Genitourinary Drugs Sales Market Forecast by Region (2026-2031)
Figure 92. Global Genitourinary Drugs Revenue Market Share Forecast by Region (2026-2031)
Figure 93. Global Genitourinary Drugs Sales Market Share Forecast by Type (2026-2031)
Figure 94. Global Genitourinary Drugs Revenue Market Share Forecast by Type (2026-2031)
Figure 95. Global Genitourinary Drugs Sales Market Share Forecast by Application (2026-2031)
Figure 96. Global Genitourinary Drugs Revenue Market Share Forecast by Application (2026-2031)